splicing modifier made to deal with SMA attributable to mutations in chromosome 5q that bring on survival motor neuron (SMN) protein deficiency. Evrysdi is administered daily at your home in liquid type by mouth or by feeding tube.This mutation brings about exon 7 to generally be skipped through pre-mRNA processing, creating the next mRNA to get qu